青光眼黄斑损伤模式与对比敏感度及面部识别能力的关联
这项前瞻性队列研究纳入72例视力良好(每眼20/40或更好)的青光眼患者共144眼,依据视盘和黄斑OCT及10-2视野损伤将黄斑损伤分为局灶型、弥漫型或混合型。结果显示,弥漫型黄斑损伤较局灶型与更差的对比敏感度和面部识别能力相关,尤其在较好眼。
要点
- 弥漫型黄斑损伤与对比敏感度下降独立相关(β=-0.5,95%CI -0.6至-0.4,P<.001)。
- 较好眼弥漫型损伤患者面部残疾相对风险显著升高(RR=86.2,95%CI 2.7至2783.3,P=.01)。
- 评估黄斑OCT与10-2视野识别弥漫型损伤有助于减少青光眼相关视觉残疾。
核心结论
- 弥漫型而非局灶型青光眼性黄斑损伤与面部识别能力下降和对比敏感度受损相关。
- 检测弥漫型黄斑损伤可能有助于减少青光眼相关视觉残疾。
研究设计与样本
- 前瞻性队列研究,单中心三级医疗中心,纳入72例连续青光眼患者共144眼,每眼视力20/40或更好。
- 数据收集于2019年3月至4月。
- 根据视盘和黄斑频域OCT及10-2视野损伤将黄斑损伤分为局灶型、弥漫型或混合型,仅纳入局灶型或弥漫型。
- 以10-2视野平均偏差确定较好眼和较差眼。
主要发现
- 72例患者中49例(68%)为白人,41例(57%)为女性,平均(SD)年龄67.0(11.6)岁。
- 校正10-2视野MD、24-2视野MD、年龄、早期白内障和滴眼液数量后,弥漫型损伤眼对比敏感度损害大于局灶型眼(β=-0.5;95%CI -0.6至-0.4;P<.001)。
- 无论较好眼还是较差眼,弥漫型黄斑损伤患者的剑桥面部记忆测试评分显著低于局灶型患者(较好眼:β=10.0;95%CI 2.0至18.2;P=.001;较差眼:β=5.5;95%CI 0.8至10.0;P=.23)。
- 较好眼弥漫型损伤患者面部残疾相对风险增高(相对风险86.2;95%CI 2.7至2783.3;P=.01),局灶型损伤未显示此关联。
关键数值与推荐
- 面部残疾定义为面部识别评分处于正常参与者的2%水平。
- 单眼对比阈值采用Freiburg视力和对比测试测量。
- 双眼面部识别采用剑桥面部记忆测试测量。
临床怎么用
- 对视力良好的青光眼患者,应结合黄斑OCT和10-2视野评估是否存在弥漫型黄斑损伤。
- 识别弥漫型黄斑损伤有助于预判对比敏感度和面部识别等日常视觉功能损害。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Facial recognition is a critical activity of daily living that relies on macular function. Glaucomatous macular damage may result in impaired facial recognition that may negatively affect patient quality of life. OBJECTIVE: To evaluate the association of patterns of glaucomatous macular damage with contrast sensitivity and facial recognition among patients with glaucoma. DESIGN, SETTING, AND PARTICIPANTS: In this prospective cohort study at a single tertiary care center, 144 eyes of 72 consecutive patients with glaucoma with good visual acuity (20/40 or better in each eye) were studied. Data were collected from March to April 2019. EXPOSURES: Eyes with macular damage were categorized as having focal, diffuse, or mixed (focal and diffuse) damage based on optic disc and macular spectral-domain optical coherence tomography and 10-2 visual field (VF) damage. Only eyes with focal or diffuse damage were included. Higher-acuity and lower-acuity eyes were determined by 10-2 VF mean deviation (MD). Facial disability was defined as facial recognition scores at the 2% level of normal participants. MAIN OUTCOMES AND MEASURES: (1) Monocular contrast threshold as measured by the Freiburg Visual Acuity and Contrast Test and (2) binocular facial recognition as measured by the Cambridge Face Memory Test. RESULTS: Of the 72 included patients, 49 (68%) were White and 41 (57%) were female, and the mean (SD) age was 67.0 (11.6) years. Eyes with diffuse damage had greater contrast impairment compared with eyes with focal damage (β = -0.5; 95% CI, -0.6 to -0.4; P < .001) after adjusting for 10-2 VF MD, 24-2 VF MD, age, presence of an early cataract, and number of drops. Similarly, Cambridge Face Memory Test scores were significantly lower in patients with diffuse rather than focal macular damage, regardless of eye (better-seeing eye: β = 10.0; 95% CI, 2.0 to 18.2; P = .001; worse-seeing eye: β = 5.5; 95% CI, 0.8 to 10.0; P = .23). Relative risk of facial disability was greater for patients with diffuse but not focal macular damage in the better-seeing eye (relative risk, 86.2; 95% CI, 2.7 to 2783.3; P = .01). CONCLUSIONS AND RELEVANCE: In this cohort study, diffuse rather than focal glaucomatous macular damage was associated with diminished facial recognition and contrast sensitivity. Evaluation of macular optical coherence tomography and 10-2 VF and resultant detection of diffuse macular damage may help minimize glaucoma-related visual disability.
引用
- Hirji SH, Hood DC, Liebmann JM, et al. Association of Patterns of Glaucomatous Macular Damage With Contrast Sensitivity and Facial Recognition in Patients With Glaucoma. JAMA Ophthalmol. 2021. PMID: 33151275. doi:10.1001/jamaophthalmol.2020.4749
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。